Exhibitors 2026 - BIOSPAIN 2026. Bilbao. Spain

ABG Intellectual Property

ABG Intellectual Property (ABG IP, previously named ABG Patentes) has been for the last 22 years one of the most important references in Europe when talking about IP services, having the largest team of patent and trademark attorneys in Spain (Madrid, Barcelona, Bilbao and Valencia):
23 European Patent Attorneys (all qualified through examination EQE)
10 Spanish Patent & Trademark Agents
4 Attorneys-at-Law
22 Ph.D.s in diverse areas of technology
5 UPC Representatives
The firm totals thirty-nine professionals with exclusive dedication, and a complete team of almost eighty people including experienced paralegals and support staff.
ABG IP advises clients ranging from individual investors, small companies and startups, universities and research institutions to big multinational corporations on patents, trademarks, designs and associated aspects of intellectual property.
Our team brings a fresh approach to IP. We work in close contact with our clients and understand their technology and fields of activity. We provide solid, valuable advice to our clients taking their needs and strategic goals into account.
ABG is known for:
- Its expertise in all technical fields. The firm’s attorneys are highly regarded for their in-depth technical knowledge, understanding of the science behind patented inventions as well as practical backgrounds. They are entrusted with cases in the most complex areas of patent law and technology;
- A deep knowledge of the European patent system, counting with 2 former EPO examiners;
- A deep knowledge of the Spanish, European and International Trademark system, counting with a former EUIPO examiner;
- Extensive experience in both Spanish and European patent, trademark and design prosecution, patent litigation proceedings and IP strategy;
- Recognized expertise in Supplementary Protection Certificates (SPC) prosecution.
- Handling of worldwide trademark portfolios including clearance searches;
- Our trademarks team is particularly strong in the defense of well-known trademarks and in the management of oppositions before the Spanish Patent and Trademark Office (SPTMO) and the European Union Intellectual Property Office (EUIPO).
- The high-quality legal and litigation services provided as a consequence of the optimization of the existing synergies in the IP field between our experienced Attorneys-at-Law and patent and trademark attorneys.
- A leading role on the implementation of trade secrets protection programs.
- A solid competence in plant variety protection.
- We are also a reference firm for the training of highly competitive IP professionals.

Asphalion

ASPHALION is an international Regulatory, Scientific & Safety consultancy company with offices in Barcelona, Madrid, Munich, London, and Pamplona. Since its foundation in 2000, ASPHALION has grown consistently to employ over 190 professionals representing more than 16 nationalities. Its strong track record has established ASPHALION as a key player in the international healthcare sector and a major contributor to the implementation of new regulatory standards.
ASPHALION provides expert consulting, strategic advice, operational support, and full outsourcing services for all product life cycle stages across all therapeutic areas. Its team offers tailored solutions for Pharmaceutical, Biotechnological, and Medical Technology companies, having successfully delivered over 5,000 projects for more than 1,000 clients from over 50 countries. Services span non-clinical and clinical development, CMC, dossier writing, regulatory procedures, vigilance, eSubmissions, and data management for both medicinal products and medical devices.
The company’s expertise is particularly notable in the field of Advanced Therapy Medicinal Products (ATMPs), where their team possesses specialized scientific knowledge and extensive regulatory experience. ATMPs require unique development strategies and regulatory adaptations due to their complexity. ASPHALION provides comprehensive support, including drafting regulatory, non-clinical, clinical, and CMC documentation essential for development, registration, and lifecycle management. Additionally, they offer strategic guidance on segmentation, niche indications, conditional approvals, fast-track processes, orphan drug designations, and preclinical and clinical development plans to minimize time-to-market.
ASPHALION has been a leader in ATMP regulatory support since 2005, participating in over 30 projects covering cell therapy (autologous and allogenic derived stem cells, CAR-T) and gene therapy (oncolytic viruses, adeno-associated virus (AAV), Modified Vaccinia Virus (MVA), Plasmids, Lentivirus, Adenovirus (AdV), and more). By collaborating closely with international competent authorities, notified bodies, scientific associations, and key opinion leaders, ASPHALION ensures the delivery of optimal solutions for every project. Their comprehensive network of geographic and functional partners further solidifies their ability to meet the needs of a dynamic and evolving healthcare landscape.